Position in GSK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$22,891,814
+$1,595,152 QoQ
Shares Held
436,700
+13.2% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
4.02%
of 13F equity value
Holder Rank
#68
of 1,033 holders
Holding Since
Sep 2020
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Sio Capital Management, LLC holds $49,578,056 across 3 Drug Manufacturers - General names. GSK ranks #1 (46.2% of the industry book) .
All Filings in GSK
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22,891,814 | 436,700 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $21,296,662 | 385,879 | Shares | Sole | 2026-05-14 | |
| 2025-09-30 | $11,604,558 | 268,873 | Shares | Sole | 2025-11-13 | |
| 2024-06-30 | $12,012,000 | 312,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $11,293,887 | 263,445 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $21,175,750 | 571,391 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $18,451,250 | 509,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $17,090,520 | 479,532 | Shares | Sole | 2023-08-14 | |
| 2022-09-30 | $23,267,358 | 790,600 | Shares | Sole | 2022-11-14 | |
| 2021-03-31 | $9,013,723 | 257,500 | Shares | Sole | 2021-05-14 | |
| 2020-09-30 | $7,628,519 | 206,638 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||